REFERENCES
- Taal W, Brandsma D, de Bruin HG, . Incidence of pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer. 2008;113:405–410.
- Brandes AA, Franceschi E, Tosoni A, . MGMT promoter methylation status can predict incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma. J Clin Oncol. 2008;26:2192–2197.
- Hoffman WF, Levin VA, Wilson CB. Evaluation of malignant glioma patients during the post-irradiation period. J Neurosurg. 1979;50:624–628.
- Dropcho, EJ, Timmerman, RD, Witt, T, . Multifocal enchancing lesions following radiotherapy for gliomas [abstract 323]. Neuro Oncol. 2001;3(Suppl):348.
- Rosenthal MA, Ashley D, Cher L, . Transient deterioration in neurological status following administration of temozolomide for high-grade glioma [abstract 394]. Neuro Oncol. 2001; 3(Suppl):366.
- Chamberlain MC, Glantz MJ, Chalmers L, . Early necrosis following temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007;82:81–83.